Pepdox
Studies
Peptides
Calculator
Letter to the Editor: Oral Semaglutide did not Significantly Improve Volumetric BMD in Overweight/Obese Type 2 Diabetes. | Pepdox
Home
/
Search
/
PMID 41062906
Letter to the Editor: Oral Semaglutide did not Significantly Improve Volumetric BMD in Overweight/Obese Type 2 Diabetes.
Calcified tissue international
2025
PMID: 41062906
View on PubMed
DOI: 10.1007/s00223-025-01437-y
Semaglutide
Authors
Daly, Robin M; Scott, David; Mesinovic, Jakub